A comparison of salivary calprotectin levels in subjects with and without oral candidiasis

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 92, Issue 1, 2001, Pages 62-67

  Kleinegger, Cynthia L ^a   Stoeckel, Daniel C ^b   Kurago, Zoya B ^a  

^a UNIVERSITY OF IOWA   (United States)

^b S Illinois Univ Sch of Dent Med   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM BINDING PROTEIN; CALGRANULIN; MEMBRANE ANTIGEN; MEMBRANE PROTEIN; NERVE CELL ADHESION MOLECULE; SALIVA PROTEIN;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BACTERIAL COUNT; CANDIDA; CANDIDA ALBICANS; CASE CONTROL STUDY; CHEMISTRY; CLASSIFICATION; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MICROBIOLOGY; MIDDLE AGED; NONPARAMETRIC TEST; RISK FACTOR; SALIVA; THRUSH;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTIGENS, SURFACE; CALCIUM-BINDING PROTEINS; CANDIDA; CANDIDA ALBICANS; CANDIDIASIS, ORAL; CASE-CONTROL STUDIES; COLONY COUNT, MICROBIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEURAL CELL ADHESION MOLECULES; RISK FACTORS; SALIVA; SALIVARY PROTEINS; STATISTICS, NONPARAMETRIC;

EID: 0035405816     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1067/moe.2001.115973     Document Type: Article

References (18)

1. Odds FC. Introduction and Historical Notes. In: Candida and candidosis. 2nd ed. London: Balliere Tindall; 1988. p. 1-6.
2. Fotos PG, Vincent SD, Hellstein JW. Oral candidosis. Clinical, historical, and therapeutic features of 100 cases. Oral Surg Oral Med Oral Pathol 1992;74:41-9.
3. Brandtzaeg P, Dale I, Fagerhol MK. Distribution of a formalin-resistant myelomonocytic antigen (L1) in human tissues. II. Normal and aberrant occurrence in various epithelia. Am J Clin Pathol 1987;87:700-7.
4. Fagerhol MK, Andersson KB, Naess-Andresen CF, Brandtzaeg P, Dale I. Calprotectin (The L1 leukocyte protein). In: Smith VL, Dedman JR, editors. Stimulus response coupling: the role of intracellular calcium-binding proteins. Boca Raton (FL): CRC Press; 1990. p. 187-210.
5. Steinbakk M, Naess-Andresen CF, Lingaas E, Dale I, Brandtzaeg P, Fagerhol MK. Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Lancet 1990;336:763-5.
6. Sohnle PG, Collins-Lech C, Wiessner JH. The zinc-reversible antimicrobial activity of neutrophil lysates and abscess fluid supernatants. J Infect Dis 1991;164:137-42.
7. Santhanagopalan V, Hahn BL, Sohnle PG. Resistance of zinc-supplemented Candida albicans cells to the growth inhibitory effect of calprotectin. J Infect Dis 1995;171:1289-94.
8. Sohnle PG, Hahn BL, Santhanagopalan V. Inhibition of Candida albicans growth by calprotectin in the absence of direct contact with the organisms. J Infect Dis 1996;174:1369-72.
9. Johne B, Fagerhol MK, Lyberg T, Prydz H, Brandtzaeg P, Naess-Andresen CF, et al. Functional and clinical aspects of the myelomonocyte protein calprotectin. Mol Pathol 1997;50:113-23.
10. Murthy AR, Lehrer RI, Harwig SS, Miyasaki KT. In vitro candidastatic properties of the human neutrophil calprotectin complex. J Immunol 1993;151:6291-301.
11. Radke LL, Hahn BL, Wagner DK, Sohnle PG. Effect of abscess fluid supernatants on the kinetics of Candida albicans growth. Clin Immunol Immunopathol 1994;73:344-9.
12. Santhanagopalan V, Hahn BL, Dünn BE, Weissner JH, Sohnle PG. Antimicrobial activity of calprotectin isolated from human empyema fluid supernatants. Clin Immunol Immunopathol 1995;76:285-90.
13. Brandtzaeg P, Gabrielsen TO, Dale I, Müller F, Steinbakk M, Fagerhol MK. The leucocyte protein L1 (calprotectin): a putative nonspecific defence factor at epithelial surfaces. Adv Exp Med Biol 1995;371A:201-6.
14. Müller F, Froland SS, Brandtzaeg P, Fagerhol MK. Oral candidiasis is associated with low levels of parotid calprotectin in individuals with infection due to human immunodeficiency virus. Clin Infect Dis 1993;16:301-2.
15. Müller F, Froland SS, Aukrust P, Fagerhol MK. Elevated serum calprotectin levels in HIV-infected patients: the calprotectin response during ZDV treatment is associated with clinical events. J Acquir Immune Defic Syndr 1994;7:931-9.
16. Cuida M, Brun JG, Tynning T, Jonsson R. Calprotectin levels in oral fluids: the importance of collection site. Eur J Oral Sci 1995;103:8-10.
17. Challacombe SJ, Sweet SP. Salivary and mucosal immune responses to HIV and its co-pathogens. Oral Dis 1997;3:S79-84.
18. Nguyen MH, Peacock JE Jr, Morris AJ, Tanner DC, Nguyen ML, Snydman DR, et al. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med 1996;100:617-23.